US biotech Cabaletta Bio (Nasdaq: CABA) has named ElevateBio as a second contract development and manufacturing organization ...

US cancer care biotech Werewolf Therapeutics and Ambros Therapeutics today announced that they entered into a definitive ...

Today, the US Food and Drug Administration published a new batch of draft product-specific guidances (PSGs) for developing ...

Chinese contract development and manufacturing group WuXi Biologics (HKEX: 2269) has agreed to sell its 51.1% stake in ...

Privately-held Italian drugmaker Alfasigma has entered into a share purchase agreement with SEVER Life Sciences (SEVER) for ...

Johnson & Johnson has announced that the European Commission (EC) has approved an indication extension for Tecvayli ...

UK-based specialty CNS-focused pharma company CNX Therapeutics today announced a distribution partnership with Innomar ...

The UK's cost-effectiveness watchdog has recommended US pharma major Eli Lilly's (NYSE: LLY) once-weekly basal insulin Onswik ...

Nearly eight years into the artificial intelligence (AI) drug discovery boom, no medicine discovered or designed with AI has ...

San Francisco-based Chai Discovery, an artificial intelligence (AI) company building computational design tools for molecules ...

Canada-based Edesa Biotech has priced an underwritten public offering expected to generate approximately $25 million in gross ...

Charles River Laboratories International and Taiwan’s Medigen Vaccine Biologics (MVC) have announced a strategic ...